Free Trial

Maplight Therapeutics (MPLT) Institutional Ownership

Maplight Therapeutics logo
$29.29 -1.38 (-4.50%)
Closing price 04:00 PM Eastern
Extended Trading
$29.36 +0.07 (+0.24%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Maplight Therapeutics (NASDAQ:MPLT)

Number of
Institutional Buyers
(last 12 months)
42
Total
Institutional Inflows
(last 12 months)
$335.62M
Number of
Institutional Sellers
(last 12 months)
0
Get MPLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Maplight Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MPLT Institutional Buying and Selling by Quarter

Maplight Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/5/2026 Bank of New York Mellon Corp39,465$802K0.0%+10.1%0.093%
2/19/2026T. Rowe Price Investment Management Inc.2,799,180$49.17M0.0%N/A6.170%
2/19/2026 Invesco Ltd.12,970$228K0.0%N/A0.029%
2/18/2026Vestal Point Capital LP385,000$6.76M0.2%N/A0.849%
2/18/2026Tudor Investment Corp ET AL47,840$840K0.0%N/A0.105%
2/18/2026Orbimed Advisors LLC56,000$952K0.0%N/A0.123%
2/18/2026Oxford Asset Management LLP17,763$312K0.1%N/A0.039%
2/18/2026Perceptive Advisors LLC550,000$9.66M0.2%N/A1.212%
2/18/2026Millennium Management LLC13,945$245K0.0%N/A0.031%
2/18/2026Baker BROS. Advisors LP364,705$6.41M0.0%N/A0.804%
2/18/20265AM Venture Management LLC950,011$16.69M5.2%N/A2.094%
2/17/2026Freestone Grove Partners LP183,771$3.23M0.0%N/A0.405%
2/17/2026Burkehill Global Management LP75,000$1.32M0.1%N/A0.165%
2/17/2026Lazard Asset Management LLC207,494$3.65M0.0%N/A0.457%
2/17/2026Jain Global LLC327,693$5.76M0.0%N/A0.722%
2/17/2026T. Rowe Price Investment Management Inc.2,799,180$49.15M0.1%N/A6.170%
2/17/2026Ghisallo Capital Management LLC20,000$351K0.0%N/A0.044%
2/17/2026Diadema Partners LP63,791$1.12M0.2%N/A0.141%
2/17/2026Fcpm Iii Services B.V.3,226,400$56.67M7.5%N/A7.111%
2/17/2026 Persistent Asset Partners Ltd21,766$382K0.2%N/A0.048%
2/17/2026 Board of Trustees of The Leland Stanford Junior University199,233$3.50M0.7%N/A0.439%
2/16/2026Nan Fung Group Holdings Ltd971,253$17.06M15.3%N/A2.141%
2/16/2026Barclays PLC26,415$464K0.0%N/A0.058%
2/13/2026Marshall Wace LLP39,659$697K0.0%N/A0.087%
2/13/2026 Walleye Capital LLC11,686$205K0.0%N/A0.026%
2/13/2026Pivotal bioVenture Partners Investment Advisor LLC611,447$10.74M4.2%N/A1.348%
2/13/2026Velan Capital Investment Management LP522,305$9.17M5.3%N/A1.151%
2/13/2026Siren L.L.C.450,000$7.90M0.2%N/A0.992%
2/13/2026Charles Schwab Investment Management Inc.138,427$2.43M0.0%N/A0.305%
2/13/2026 Police & Firemen s Retirement System of New Jersey3,986$70K0.0%N/A0.009%
2/13/2026State Street Corp229,484$4.03M0.0%N/A0.506%
2/13/2026 Wells Fargo & Company MN18,687$328K0.0%N/A0.041%
2/12/2026MetLife Investment Management LLC9,798$172K0.0%N/A0.022%
2/12/2026 New York State Common Retirement Fund5,300$93K0.0%N/A0.012%
2/12/2026 Nuveen LLC20,197$355K0.0%N/A0.045%
2/11/2026 Deutsche Bank AG11,928$210K0.0%N/A0.026%
2/11/2026 Sanofi912,041$16.02M5.2%N/A2.010%
2/10/2026 TD Asset Management Inc36,960$649K0.0%N/A0.081%
2/10/2026Goldman Sachs Group Inc.1,937,168$34.03M0.0%N/A4.270%
2/10/2026 Seven Grand Managers LLC100,000$1.76M0.1%N/A0.220%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
2/9/2026Geode Capital Management LLC389,026$6.84M0.0%N/A0.857%
2/9/2026Blue Owl Capital Holdings LP327,058$5.75M0.4%N/A0.721%
2/2/2026 Strs Ohio3,000$53K0.0%N/A0.007%


MPLT Institutional Ownership - Frequently Asked Questions

During the previous two years, 42 institutional investors and hedge funds held shares of Maplight Therapeutics. The most heavily invested institutionals were Fcpm Iii Services B.V. ($56.67M), T. Rowe Price Investment Management Inc. ($49.17M), Goldman Sachs Group Inc. ($34.03M), Nan Fung Group Holdings Ltd ($17.06M), 5AM Venture Management LLC ($16.69M), Sanofi ($16.02M), and Pivotal bioVenture Partners Investment Advisor LLC ($10.74M).Learn more on Maplight Therapeutics' institutional investors.

Of the 42 institutional investors that purchased Maplight Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: T. Rowe Price Investment Management Inc. ($5.60M), Fcpm Iii Services B.V. ($3.23M), Goldman Sachs Group Inc. ($1.94M), Nan Fung Group Holdings Ltd ($971.25K), 5AM Venture Management LLC ($950.01K), Sanofi ($912.04K), and Pivotal bioVenture Partners Investment Advisor LLC ($611.45K).

Institutional investors have bought a total of 19,101,175 shares in the last 24 months. This purchase volume represents approximately $335.62M in transactions.



This page (NASDAQ:MPLT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners